Operating Income (Loss) in USD of Rallybio Corp from Q2 2020 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Rallybio Corp quarterly/annual Operating Income (Loss) history and change rate from Q2 2020 to Q3 2025.
- Rallybio Corp Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$6.93M, a 42.6% increase year-over-year.
- Rallybio Corp Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$38.3M, a 45.3% increase year-over-year.
- Rallybio Corp annual Operating Income (Loss) for 2024 was -$60.5M, a 23.4% increase from 2023.
- Rallybio Corp annual Operating Income (Loss) for 2023 was -$78.9M, a 16.3% decline from 2022.
- Rallybio Corp annual Operating Income (Loss) for 2022 was -$67.9M, a 48.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)